Overview

Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer

Status:
Not yet recruiting
Trial end date:
2024-08-31
Target enrollment:
Participant gender:
Summary
This study is a randomized phase II trial of maintenance chemotherapy versus consolidative radiotherapy plus maintenance chemotherapy for patients with unresectable metastatic colorectal cancer (MCRC).
Phase:
Phase 2
Details
Lead Sponsor:
Wuhan Union Hospital, China